103 related articles for article (PubMed ID: 38732188)
1. Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis.
Lindell E; Zhang X
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732188
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers.
Zeng J; Jiang WG; Sanders AJ
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356662
[TBL] [Abstract][Full Text] [Related]
3. EPLIN: a fundamental actin regulator in cancer metastasis?
Collins RJ; Jiang WG; Hargest R; Mason MD; Sanders AJ
Cancer Metastasis Rev; 2015 Dec; 34(4):753-64. PubMed ID: 26350886
[TBL] [Abstract][Full Text] [Related]
4. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.
Collins RJ; Morgan LD; Owen S; Ruge F; Jiang WG; Sanders AJ
Int J Cancer; 2018 Nov; 143(10):2537-2550. PubMed ID: 30098000
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton.
Song Y; Maul RS; Gerbin CS; Chang DD
Mol Biol Cell; 2002 Apr; 13(4):1408-16. PubMed ID: 11950948
[TBL] [Abstract][Full Text] [Related]
7. EPLIN regulates actin dynamics by cross-linking and stabilizing filaments.
Maul RS; Song Y; Amann KJ; Gerbin SC; Pollard TD; Chang DD
J Cell Biol; 2003 Feb; 160(3):399-407. PubMed ID: 12566430
[TBL] [Abstract][Full Text] [Related]
8. EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome.
Liu Y; Sanders AJ; Zhang L; Jiang WG
Anticancer Res; 2012 Apr; 32(4):1283-9. PubMed ID: 22493360
[TBL] [Abstract][Full Text] [Related]
9. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.
Jiang WG; Martin TA; Lewis-Russell JM; Douglas-Jones A; Ye L; Mansel RE
Mol Cancer; 2008 Sep; 7():71. PubMed ID: 18796137
[TBL] [Abstract][Full Text] [Related]
10. Extracellular signal-regulated kinase/mitogen-activated protein kinase regulates actin organization and cell motility by phosphorylating the actin cross-linking protein EPLIN.
Han MY; Kosako H; Watanabe T; Hattori S
Mol Cell Biol; 2007 Dec; 27(23):8190-204. PubMed ID: 17875928
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition.
Zhang S; Wang X; Iqbal S; Wang Y; Osunkoya AO; Chen Z; Chen Z; Shin DM; Yuan H; Wang YA; Zhau HE; Chung LW; Ritenour C; Kucuk O; Wu D
J Biol Chem; 2013 Jan; 288(3):1469-79. PubMed ID: 23188829
[TBL] [Abstract][Full Text] [Related]
12. The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts.
Hecht M; Alber N; Marhoffer P; Johnsson N; Gronemeyer T
Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38719752
[TBL] [Abstract][Full Text] [Related]
13. The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis.
Sanders AJ; Ye L; Mason MD; Jiang WG
Angiogenesis; 2010 Dec; 13(4):317-26. PubMed ID: 20848180
[TBL] [Abstract][Full Text] [Related]
14. Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro.
Chervin-Pétinot A; Courçon M; Almagro S; Nicolas A; Grichine A; Grunwald D; Prandini MH; Huber P; Gulino-Debrac D
J Biol Chem; 2012 Mar; 287(10):7556-72. PubMed ID: 22194609
[TBL] [Abstract][Full Text] [Related]
15. EPLIN-β is a novel substrate of ornithine decarboxylase antizyme 1 and mediates cellular migration.
Li D; Neo SP; Gunaratne J; Sabapathy K
J Cell Sci; 2023 Jun; 136(12):. PubMed ID: 37325974
[TBL] [Abstract][Full Text] [Related]
16. Epithelial protein lost in neoplasm modulates platelet-derived growth factor-mediated adhesion and motility of mesangial cells.
Tsurumi H; Harita Y; Kurihara H; Kosako H; Hayashi K; Matsunaga A; Kajiho Y; Kanda S; Miura K; Sekine T; Oka A; Ishizuka K; Horita S; Hattori M; Hattori S; Igarashi T
Kidney Int; 2014 Sep; 86(3):548-57. PubMed ID: 24694988
[TBL] [Abstract][Full Text] [Related]
17. EPLIN, epithelial protein lost in neoplasm.
Maul RS; Chang DD
Oncogene; 1999 Dec; 18(54):7838-41. PubMed ID: 10618726
[TBL] [Abstract][Full Text] [Related]
18. SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization.
Seong BK; Lau J; Adderley T; Kee L; Chaukos D; Pienkowska M; Malkin D; Thorner P; Irwin MS
Oncogene; 2015 Jul; 34(27):3582-92. PubMed ID: 25220418
[TBL] [Abstract][Full Text] [Related]
19. Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm.
Chen NP; Uddin B; Hardt R; Ding W; Panic M; Lucibello I; Kammerer P; Ruppert T; Schiebel E
Proc Natl Acad Sci U S A; 2017 May; 114(20):5201-5206. PubMed ID: 28465438
[TBL] [Abstract][Full Text] [Related]
20. Epithelial Protein Lost in Neoplasm alpha (Eplin-alpha) is transcriptionally regulated by G-actin and MAL/MRTF coactivators.
Leitner L; Shaposhnikov D; Descot A; Hoffmann R; Posern G
Mol Cancer; 2010 Mar; 9():60. PubMed ID: 20236507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]